Application of Bayesian Dynamic Linear Models to Random Allocation Clinical Trials

Random allocation models used in clinical trials aid researchers in determining which of a particular treatment provides the best results by reducing bias between groups. Often however, this determination leaves researchers battling ethical issues of providing patients with unfavorable treatments. Many methods such as Play the Winner and Randomized Play the Winner Rule have historically been utilized to determine patient allocation, however, these methods are prone to the increased assignment of unfavorable treatments. Recently a new Bayesian Method using Decreasingly Informative Priors has been proposed by \citep{sabo2014adaptive}, and later \citep{donahue2020allocation}. Yet this method can be time consuming if MCMC methods are required. We propose the use of a new method which uses Dynamic Linear Model (DLM) \citep{harrison1999bayesian} to increase allocation speed while also decreasing patient allocation samples necessary to identify the more favorable treatment. Furthermore, a sensitivity analysis is conducted on multiple parameters. Finally, a Bayes Factor is calculated to determine the proportion of unused patient budget remaining at a specified cut off and this will be used to determine decisive evidence in favor of the better treatment.

[1]  Giovanni Petris,et al.  Dynamic Linear Models with R , 2009 .

[2]  L. J. Wei,et al.  The Generalized Polya's Urn Design for Sequential Medical Trials , 1979 .

[3]  T. Colton A Model for Selecting One of Two Medical Treatments , 1963 .

[4]  William F Rosenberger,et al.  Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes , 2006, Biometrics.

[5]  Roy T Sabo Adaptive Allocation for Binary Outcomes Using Decreasingly Informative Priors , 2014, Journal of biopharmaceutical statistics.

[6]  H. Robbins Some aspects of the sequential design of experiments , 1952 .

[7]  N Stallard,et al.  Optimal Adaptive Designs for Binary Response Trials , 2001, Biometrics.

[8]  F. J. Anscombe Sequential Medical Trials , 1963 .

[9]  W. Johnson,et al.  The Bayesian Two-Sample t Test , 2005 .

[10]  Edward S. Kim,et al.  Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine , 2008, Clinical trials.

[11]  Kristine Broglio,et al.  Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. , 2013, Journal of clinical epidemiology.

[12]  D. Berry,et al.  Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial. , 2012, American heart journal.

[13]  G. Parmigiani,et al.  Bayesian adaptive randomized trial design for patients with recurrent glioblastoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  W F Rosenberger,et al.  Randomized play-the-winner clinical trials: review and recommendations. , 1999, Controlled clinical trials.

[15]  W. R. Thompson ON THE LIKELIHOOD THAT ONE UNKNOWN PROBABILITY EXCEEDS ANOTHER IN VIEW OF THE EVIDENCE OF TWO SAMPLES , 1933 .

[16]  Anastasia Ivanova,et al.  A play-the-winner-type urn design with reduced variability , 2003 .

[17]  D. Berry Bayesian clinical trials , 2006, Nature Reviews Drug Discovery.

[18]  L. J. Wei,et al.  The Randomized Play-the-Winner Rule in Medical Trials , 1978 .

[19]  Ghalib A. Bello,et al.  Optimal and lead-in adaptive allocation for binary outcomes: A comparison of Bayesian methods , 2017, Communications in statistics: theory and methods.

[20]  P. Thall,et al.  Practical Bayesian adaptive randomisation in clinical trials. , 2007, European journal of cancer.

[21]  M. Zelen,et al.  Play the Winner Rule and the Controlled Clinical Trial , 1969 .